MedPath

ROBOT trial: Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy vs. open transthoracic esophagectomy: A randomized controlled trial.

Completed
Conditions
Esophageal carcinomaSlokdarmcrinoom
Registration Number
NL-OMON28386
Lead Sponsor
niversity Medical Center Utrecht
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
112
Inclusion Criteria

1. Histologically proven squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus;

2. Surgical resectable (T1-4a, N0-3, M0);

Exclusion Criteria

1. Carcinoma of the cervical esophagus;

2. Carcinoma of the gastro-esophageal junction (GEJ) with major tumor in the gastric cardia (Siewert III);

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The percentage of overall complications (Grade 2 and higher) as stated by the modified Clavien-Dindo classification.
Secondary Outcome Measures
NameTimeMethod
Iindividual components of the primary endpoint (major and minor complications), (in hospital) mortality within 30 and 60 days, R0 resections, operation related events, postoperative recovery, oncologic outcomes, cost-effectiveness and quality of life.
© Copyright 2025. All Rights Reserved by MedPath